相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options
Jesus Gonzalez Bosquet et al.
PLOS ONE (2021)
PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer
Jesus Gonzalez-Bosquet et al.
GYNECOLOGIC ONCOLOGY (2021)
Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach
Samuele Lodovichi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Comparing mutation frequencies for homologous recombination genes in uterine serous and high-grade serous ovarian carcinomas: A case for homologous recombination deficiency testing in uterine serous carcinoma
John J. Wallbillich et al.
GYNECOLOGIC ONCOLOGY (2020)
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Michiel Remmerie et al.
FRONTIERS IN ONCOLOGY (2019)
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression
Charles W. Ashley et al.
GYNECOLOGIC ONCOLOGY (2019)
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Giovanna Damia et al.
CANCERS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy
Lucia Tortorella et al.
GYNECOLOGIC ONCOLOGY (2018)
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back
Jukka Westermarck
FEBS JOURNAL (2018)
Predicting proteome dynamics using gene expression data
Krzysztof Kuchta et al.
SCIENTIFIC REPORTS (2018)
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Kevin Brasseur et al.
ONCOTARGET (2017)
CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
Katherine C. Kurnit et al.
MODERN PATHOLOGY (2017)
All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
Jaya Sangodkar et al.
FEBS JOURNAL (2016)
Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Gabriela Nestal de Moraes et al.
CURRENT DRUG TARGETS (2016)
Gene-specific correlation of RNA and protein levels in human cells and tissues
Fredrik Edfors et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance
Catherine A. Cremona et al.
SEMINARS IN CANCER BIOLOGY (2016)
Tumor grade and chemotherapy response in endometrioid endometrial cancer
Brittany A. Davidson et al.
GYNECOLOGIC ONCOLOGY REPORTS (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Orchestrating high-throughput genomic analysis with Bioconductor
Wolfgang Huber et al.
NATURE METHODS (2015)
To live or let die - complexity within the E2F1 pathway
A. Poppy Roworth et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy
Jamie N. Bakkum-Gamez et al.
GYNECOLOGIC ONCOLOGY (2014)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
Anni Laine et al.
CANCER DISCOVERY (2013)
FOXM1: From cancer initiation to progression and treatment
Chuay-Yeng Koo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies
Thomas Hogberg et al.
EUROPEAN JOURNAL OF CANCER (2010)
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Jessica Plati et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group study
D. Scott McMeekin et al.
GYNECOLOGIC ONCOLOGY (2007)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
ME Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
E2F target genes: unraveling the biology
AP Bracken et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
分享论文
